Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-21-089414
Filing Date
2021-07-06
Accepted
2021-07-06 16:13:26
Documents
1
Period of Report
2021-07-01

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2121302d4_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2121302d4_4seq1.xml 4 4167
  Complete submission text file 0001104659-21-089414.txt   5591
Mailing Address 259 LIBERTY AVENUE STATEN ISLAND NY 10305
Business Address 259 LIBERTY AVENUE STATEN ISLAND NY 10305 917-533-1469
Acurx Pharmaceuticals, Inc. (Issuer) CIK: 0001736243 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 4 GREENBRIAR LANE MONTVALE NJ 07645
Business Address
Sailer Carl (Reporting) CIK: 0001854182 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40536 | Film No.: 211074213